Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Open accessThe DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations to PKD1 or PKD2, triggering progressive cystogenesis and typically leading to end-stage renal disease in midlife. The phenotypic spectrum, however, ranges from in utero onset to adequate renal function at old age. Recent patient data suggest that the disease is dosage dependent, where incompletely penetrant alleles influence disease severity. Here, we have developed a knockin mouse model matching a likely disease variant, PKD1 p.R3277C (RC), and have proved that its functionally hypomorphic nature modifies the ADPKD phenotype. While Pkd1+/null mice are normal, Pkd1RC/null mice have rapidly progressive disease, and Pkd1RC/RC animals develop gradual cystogenesis. These models effectively mimic the pathophysiological features of in utero-onset and typical ADPKD, respectively, correlating the level of functional Pkd1 product with disease severity, highlighting the dosage dependence of cystogenesis. Additionally, molecular analyses identified p.R3277C as a temperature-sensitive folding/trafficking mutant, and length defects in collecting duct primary cilia, the organelle central to PKD pathogenesis, were clearly detected for the first time to our knowledge in PKD1. Altogether, this study highlights the role that in trans variants at the disease locus can play in phenotypic modification of dominant diseases and provides a truly orthologous PKD1 model, optimal for therapeutic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [427]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and proteomic profiling of exosomes in human urine
Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403453101 · Cited by 2,174 · cited 2×
“21, 22).”
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057 · cited 2×
“However, in PKD1, the majority of studies have not detected cilia length defects, but the data are not conclusive, as these studies were largely conducted by light microscopy using cultured cells (14, 15, 80, 81).”
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Self-citationPKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406 · cited 1×
“3) and PKD2 (4q21), mutated in approximately 85% and 15% of cases, respectively (3–5).”
Hildebrandt, F., Benzing, T., & Katsanis, N. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1010172 · Cited by 1,331
A Highly Efficient Recombineering-Based Method for Generating Conditional Knockout Mutations
Liu, P., Jenkins, N. A., & Copeland, N. G. (2003) · Genome Research · doi:10.1101/gr.749203 · Cited by 1,013 · cited 1×
“A β -lactamase expression cassette flanked with a 3 ′ Sal I site was recom-bineered into IVS30, using the DY380 E. coli strain (63).”
Yoder, B. K., Hou, X., & Guay-Woodford, L. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000029587.47950.25 · Cited by 935
Hughes, J., Ward, C. J., Peral, B., Aspinwall, R., Clark, K., San Millán, J. L., Gamble, V., & Harris, P. C. (1995) · Nature Genetics · doi:10.1038/ng0695-151 · Cited by 910 · cited 1×
“82, 83).”
Self-citationDise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818 · cited 1×
“One possibility is that the PC complex acts as a mechanosensor, signaling via a Ca 2+ influx through PC-2, a TRP channel, after fluid flow detection by PC-1 (14, 16, 20).”
Cited by
Items 101–200 of 480
The Mutation, a Key Determinant of Phenotype in ADPKD
Harris, P. C., & Hopp, K. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040417 · Cited by 45
Self-citationTherapeutic microRNAs in polycystic kidney disease
Yheskel, M., & Patel, V. (2017) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0000000000000333 · Cited by 44
Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease
Idowu, J. Y., Home, T., Patel, N., Magenheimer, B. S., Tran, P. V., Maser, R. L., Ward, C. J., Calvet, J. P., Wallace, D. P., & Sharma, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21132-3 · Cited by 43
Self-citationZhang, Y., Dai, Y., Raman, A., Daniel, E. A., Metcalf, J., Reif, G. A., Pierucci‐Alves, F., & Wallace, D. P. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00366.2020 · Cited by 44
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
Bais, T., Gansevoort, R. T., & Meijer, E. (2022) · Drugs · doi:10.1007/s40265-022-01745-9 · Cited by 43
The deubiquitinating enzyme Usp14 controls ciliogenesis and Hedgehog signaling
Massa, F., Tammaro, R., Prado, M. A., Cesana, M., Lee, B., Finley, D. J., Franco, B., & Morleo, M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy380 · Cited by 42
Kataoka, H., Fukuoka, H., Makabe, S., Yoshida, R. Y., Teraoka, A., Ushio, Y., Akihisa, T., Manabe, S., Sato, M., Mitobe, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010146 · Cited by 42
“R3277C (RC) was used showed that progression was slower in PKD1RC/RC mice than in PKD1RC/null ones [24].”
MethodPadhy, B., Xie, J., Wang, R., Lin, F. H., & Huang, C. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022010053 · Cited by 41
Calcium-permeable ion channels in the kidney
Zhou, Y., & Greka, A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00117.2016 · Cited by 41
“Studies have shown elevated levels of cAMP and upregulated PKA activity in animal models of PKD (44, 71, 159).”
BackgroundGonzález-Paredes, F. J., Ramos‐Trujillo, E., & Claveríe‐Martín, F. (2014) · Gene · doi:10.1016/j.gene.2014.06.004 · Cited by 40
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis
Kashyap, S., Hein, K. Z., Chini, C. C. S., Lika, J., Warner, G. M., Bale, L. K., Torres, V. E., Harris, P. C., Oxvig, C., Conover, C. A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135700 · Cited by 41
“by crossing the PAPP-A-deficient Pappa tm1Cac mice (81) with the Pkd1 RC/RC mice (82).”
MethodSelf-citationClaveríe‐Martín, F., González-Paredes, F. J., & Ramos‐Trujillo, E. (2015) · RNA Biology · doi:10.1080/15476286.2015.1014291 · Cited by 39
“However, previous studies have shown that a decrease in PKD1 expression can generate the disease onset or affect the severity of the phenotype.(51,52) Consequently, the reduction of PKD1 expression due to the splicing defect in patients with mutation c.”
BackgroundKline, T. L., Irazabal, M. V., Ebrahimi, B., Hopp, K., Udoji, K. N., Warner, J., Korfiatis, P. D., Mishra, P. K., Macura, S. I., Venkatesh, S. K., et al. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25701 · Cited by 39
“A mouse model that closely mirrors ADPKD in humans both genetically and phenotypically has been used (20).”
BackgroundMethodSelf-citationGenetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes
Yang, H., Sieben, C. J., Schauer, R. S., & Harris, P. C. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.04.004 · Cited by 39
Self-citationNiborski, L. L., Paces-Fessy, M., Ricci, P., Bourgeois, A., Magalhães, P., Kuzma‐Kuzniarska, M., Lesaulnier, C., Reczko, M., Declercq, E., Zürbig, P., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047498 · Cited by 38
“A significant increase in the levels of alanine aminotransferase (ALT) and a tendency for higher levels of aspartate aminotransferase (AST) were observed, reflecting potential liver dysfunction in heterozygous mutant mice, as reported in some RCAD patients (Iwasaki et al., 1998).”
BackgroundDaneshgar, N., Baguley, A., Liang, P., Wu, F., Chu, Y., Kinter, M. T., Benavides, G. A., Johnson, M. S., Darley-Usmar, V. M., Zhang, J., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02730-w · Cited by 38
On the constitutionality of school fees : a reply to Roithmayr : research article
Fleisch, B. (2004) · Perspectives in Education · Cited by 38
Radiologic and Clinical Bronchiectasis Associated with Autosomal Dominant Polycystic Kidney Disease
Moua, T., Zand, L., Hartman, R. P., Hartman, T. E., Qin, D., Peikert, T., & Qian, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093674 · Cited by 37
“The contributing genetic defects are found in polycystin-1 and 2, two transmembrane regulatory proteins responsible for mechanoreception, cell polarization, and orientation [3,4].”
BackgroundHolditch, S. J., Brown, C. N., Atwood, D. J., Lombardi, A. M., Nguyen, K. N., Toll, H. W., Hopp, K., & Edelstein, C. L. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00051.2019 · Cited by 37
Self-citationIn silico biological discovery with large perturbation models
Miladinovic, D., Höppe, T., Chevalley, M., Georgiou, A., Stuart, L., Mehrjou, A., Bantscheff, M., Schölkopf, B., & Schwab, P. (2025) · Nature Computational Science · doi:10.1038/s43588-025-00870-1 · Cited by 36
“Data access to the Optum © de-identified Electronic Health Record database may require a data sharing agreement and may incur data access fees. prepublication draft 4 Materials and methods”
Al‐Hamed, M. H., Alsahan, N., Rice, S. J., Edwards, N., Nooreddeen, E., Alotaibi, M., Kurdi, W., Alnemer, M., Altaleb, N., Ali, W., et al. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04267-x · Cited by 36
Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease
Hopp, K., Kleczko, E. K., Gitomer, B. Y., Chonchol, M., Klawitter, J., Christians, U., & Klawitter, J. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2021 · Cited by 37
Self-citationThe regulatory 1α subunit of protein kinase A modulates renal cystogenesis
Ye, H., Wang, X., Constans, M., Sussman, C. R., Chebib, F. T., Irazabal, M. V., Young, W. F., Harris, P. C., Kirschner, L. S., & Torres, V. E. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2017 · Cited by 36
“To ascertain the role of PKA-R1 and PKA in the pathogenesis of ADPKD we used Prkar1a floxed (22) and Pkhd1-Cre mice (46) to generate mice with a kidney-specific knockout of Prkar1a alone or in combination with a hypomorphic Pkd1 genotype (Pkd1 or Pkd1) (17).”
BackgroundMethodSelf-citationRole of the polycystins as mechanosensors of extracellular stiffness
Nigro, E. A., & Boletta, A. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00545.2020 · Cited by 35
Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease
Blanco, G. V., & Wallace, D. P. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00248.2013 · Cited by 35
Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing
Sieben, C. J., & Harris, P. C. (2023) · Kidney360 · doi:10.34067/kid.0000000000000209 · Cited by 33
Self-citationPrimary Cilia in Cystic Kidney Disease
Avasthi, P. P., Maser, R. L., & Tran, P. V. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_11 · Cited by 35
“Elevated intracellular cAMP is common to cystic kidneys of both orthologous Pkd and ciliary mouse models: the former including Pkd1 (Hopp et al. 2012) and Pkd2 (Torres et al. 2004) mutant mice and the Pkhd1-mutant Polycystic Kidney (PCK) rat (Wang et al. 2008), while the latter group including pcy…”
BackgroundInfluentialAdhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation
Maser, R. L., & Calvet, J. P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109637 · Cited by 38
Dwivedi, N., Jamadar, A., Mathew, S., Fields, T. A., & Rao, R. (2022) · Kidney International · doi:10.1016/j.kint.2022.08.036 · Cited by 30
PKD1 Mono-Allelic Knockout Is Sufficient to Trigger Renal Cystogenesis in a Mini-Pig Model
He, J. H., Li, Q., Fang, S., Guo, Y., Liu, T., Ye, J., Yu, Z., Zhang, R., Zhao, Y., Hu, X., et al. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10858 · Cited by 30
“Our results are similar to the recent report of Hopp et al, who demonstrated in a mouse ADPKD model that cysts originating from the LH and DT were consistently <1% [28].”
Resultc-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis
Parrot, C., Kurbegovic, A., Yao, G., Couillard, M., Côté, O., & Trudel, M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy379 · Cited by 30
Koslowski, S., Latapy, C., Auvray, P., Blondel, M., & Meijer, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124537 · Cited by 30
“described a new murine model carrying an hypomorphic Pkd1 allele, the Pkd1RC/RC mouse [173].”
BackgroundPolycystic Kidney/Liver Disease
Roediger, R., Dieterich, D. T., Chanumolu, P., & Deshpande, P. P. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.009 · Cited by 29
Developmental signaling: Does it bridge the gap between cilia dysfunction and renal cystogenesis?
Tran, P. V., Sharma, M., Li, X., & Calvet, J. P. (2014) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21065 · Cited by 29
“5 Pkd12/2;TCF-lacZ1 renal cystlining epithelia, and increased levels of total and active bcatenin in Pkd12/2 whole kidney lysates (Qin et al., 2012).”
InfluentialInhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease
Montford, J. R., Bauer, C. D., Dobrinskikh, E., Hopp, K., Levi, M., Weiser‐Evans, M. C. M., Nemenoff, R. A., & Furgeson, S. B. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00262.2018 · Cited by 29
Self-citationNguyen, D. T., Kleczko, E. K., Dwivedi, N., Monaghan, M. T., Gitomer, B. Y., Chonchol, M. B., Clambey, E. T., Nemenoff, R. A., Klawitter, J., & Hopp, K. (2023) · JCI Insight · doi:10.1172/jci.insight.154773 · Cited by 28
“Here, we utilize an orthologous ADPKD model to study tryptophan metabolism in PKD (41, 44, 45).”
Self-citationMechanisms of Cyst Development in Polycystic Kidney Disease
Qiu, J., Germino, G. G., & Menezes, L. F. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.03.001 · Cited by 28
Polycystins and Mechanotransduction in Human Disease
Gargalionis, A. N., Basdra, E. K., & Papavassiliou, A. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092182 · Cited by 28
“However, the complexity of the cyst f rmation and respective studies ighlighted the t reshold model for cystogenesis in ADPKD, according t w ich cysts are f rme when the functions of polycystins fall below a specific dosage [21,22].”
BackgroundHypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease
Theodorakopoulou, M. P., Raptis, V., Loutradis, C., & Sarafidis, P. A. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.10.009 · Cited by 28
Multiomics profiling of mouse polycystic kidney disease progression at a single-cell resolution
Muto, Y., Yoshimura, Y., Wu, H., Chang-Panesso, M., Ledru, N., Woodward, O. M., Outeda, P., Cheng, T., Mahjoub, M. R., Watnick, T. J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2410830121 · Cited by 29
“The Pkd1 p.R3269C knock - in mice [equivalent to human PKD1 p.R3277C mutation ( Pkd1 RC/RC )] (45, 49) were analyzed at 11 mo of age (2 female and 1 male mouse kidneys).”
A Multitubular Kidney-on-Chip to Decipher Pathophysiological Mechanisms in Renal Cystic Diseases
Myram, S., Venzac, B., Lapin, B., Battistella, A., Cayrac, F., Cinquin, B. P., Cavaniol, C., Gropplero, G., Bonnet, I., Demolombe, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.624553 · Cited by 27
“, 2018), but with possible underestimation of the proximal contribution due to differentiation issues (Hopp et al., 2012), and high sensitivity to initial conditions (Leonhard et al.”
BackgroundATP release into ADPKD cysts via pannexin-1/P2X7 channels decreases ENaC activity
Arkhipov, S. N., & Pavlov, T. S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.177 · Cited by 27
“Our study investigates cystic expression of pannexin-1 and P2X7 in Pkd1RC/RC mice, a rodent model of ADPKD [33], and their involvement in ATP release which serves as a pathogenic factor reducing sodium reabsorption in cystogenesis.”
BackgroundThe GPCR properties of polycystin-1- A new paradigm
Maser, R. L., Calvet, J. P., & Parnell, S. C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1035507 · Cited by 31
“For instance, the hypomorphic Pkd1 model is cystic due to decreased expression levels of PC1 (Hopp et al., 2012), but the protein retains an intact C-tail presumably capable of interacting”
BackgroundArs, E., & Torrá, R. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx051 · Cited by 26
“Similarly, the type of PKD1 mutation influences renal outcome in ADPKD [26] since the extent of cyst formation in ADPKD is inversely correlated with the level of polycystin-1 function [27].”
BackgroundNovel GANAB variants associated with polycystic liver disease
van de Laarschot, L. F. M., Morsche, R. H. M. T., Hoischen, A., Venselaar, H., Roelofs, H. M. J., Cnossen, W. R., Bañales, J. M., Roepman, R., & Drenth, J. P. H. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01585-4 · Cited by 26
Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease
Wang, X., Jiang, L., Thao, K., Sussman, C. R., LaBranche, T., Palmer, M., Harris, P. C., McKnight, G. S., Hoeflich, K. P., Schalm, S., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021081125 · Cited by 26
Self-citationChang, M., Chen, H.-M., Jenq, C., Lee, S., Chen, Y.-M., Tian, Y., Chen, Y., Hung, C., Fang, J., Yang, C.-W., et al. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.91 · Cited by 25
Polycystic kidney disease – where gene dosage counts
Eccles, M. R., & Stayner, C. (2014) · F1000Prime Reports · doi:10.12703/p6-24 · Cited by 25
“In a follow-on paper the Harris group then developed a “knock-in” mouse model containing the RC variant allele and demonstrated that it was indeed a functionally hypomorphic allele capable of affecting the severity of ADPKD in mice [26].”
BackgroundMurine models of polycystic kidney disease
Menezes, L. F., & Germino, G. G. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.10.002 · Cited by 24
“These mice survived into adulthood and developed progressive PKD [18].”
BackgroundMasyuk, T. V., Lee, S. O., Radtke, B. N., Stroope, A. J., Huang, B. Q., Bañales, J. M., Masyuk, A. I., Splinter, P. L., Gradilone, S. A., Gajdos, G. B., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.021 · Cited by 24
MicroRNAs and Polycystic Kidney Disease
Hajarnis, S. S., Lakhia, R., & Patel, V. (2015) · Codon Publications eBooks · doi:10.15586/codon.pkd.2015.ch13 · Cited by 24
Atwood, D. J., Pokhrel, D., Brown, C. N., Holditch, S. J., Bachu, D. M., Thorburn, A. M., Hopp, K., & Edelstein, C. L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109730 · Cited by 24
Self-citationVerschuren, E. H. J., Mohammed, S. G., Leonhard, W. N., Bos, C., Veraar, K., Hoenderop, J. G. J., Bindels, R. J. M., Peters, D. J. M., & Arjona, F. J. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00622.2017 · Cited by 23
Zhu, P., Qiu, Q., Harris, P. C., Xu, X., & Lin, X. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020070991 · Cited by 23
Self-citationEnhancer and super-enhancer landscape in polycystic kidney disease
Lakhia, R., Mishra, A., Biggers, L. M., Malladi, V. S., Cobo-Stark, P., Hajarnis, S. S., & Patel, V. (2021) · Kidney International · doi:10.1016/j.kint.2022.08.039 · Cited by 23
Cordido, A., Cernadas, E., Fernández-Delgado, M., & García-González, M. Á. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008337 · Cited by 22
Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice
Tham, M. S., Cottle, D. L., Zylberberg, A. K., Short, K. M., Jones, L. K., Chan, P., Conduit, S. E., Dyson, J. M., Mitchell, C. A., & Smyth, I. (2024) · Nature Communications · doi:10.1038/s41467-023-44410-9 · Cited by 22
“To do so we utilised the Pkd1 RC model which includes a hypomorphic Pkd1 variant fi rst identi fi ed in an ADPKD patient 45 .”
Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression
Clerici, S., Podrini, C., Stefanoni, D., Distefano, G., Cassina, L., Steidl, M. E., Tronci, L., Canu, T., Chiaravalli, M., Spies, D., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00071-9 · Cited by 22
“…not sufficient for the establishment of the pathology, thus it has been proposed that a second hit causing loss of heterozygosity is needed to drop polycystins’ complex functional activity under a critical threshold (Qian et al , 1996; Watnick et al , 2000; Leeuwen et al , 2004; Hopp et al , 2012).”
BackgroundHuman Polycystin-2 Transgene Dose-Dependently Rescues ADPKD Phenotypes in Pkd2 Mutant Mice
Li, A., Tian, X., Zhang, X., Huang, S., Ma, Y., Wu, D., Moeckel, G. W., Somlo, S., & Wu, G. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.06.014 · Cited by 22
Mukherjee, M., Ratnayake, I. S., Janga, M. R., Fogarty, E., Scheidt, S., Grassmeyer, J. J., deRiso, J., Chandrasekar, I., Ahrenkiel, P., Kopan, R., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902358rr · Cited by 22
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies
Dvela‐Levitt, M., Shaw, J. L., & Greka, A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.11.008 · Cited by 22
Kataoka, H., Watanabe, S., Sato, M., Manabe, S., Makabe, S., Akihisa, T., Ushio, Y., Iwasa, N., Yoshida, R. Y., Tsuchiya, K., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10176-9 · Cited by 22
MicroRNAs and polycystic kidney disease
Noureddine, L. A., Hajarnis, S. S., & Patel, V. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2013.10.001 · Cited by 22
“Reduced gene dosage of ADPKD genes has been proposed as a new mechanism for cyst pathogenesis (58-60).”
BackgroundGlycosylation in kidney diseases
Ling, Y., Cai, F., Su, T., Zhong, Y., Li, L., Meng, B., Li, G., Gong, M., Yang, H., Xie, X., et al. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf017 · Cited by 21
“PC1 and PC2 inhibit cyst formation in a dose-dependent manner; cysts develop when the concentration of PC1 or PC2 falls below a certain threshold [ 174 , 175 ].”
Mise, A. D., Wang, X., Ye, H., Pellegrini, L., Torres, V. E., & Valenti, G. (2021) · The FASEB Journal · doi:10.1096/fj.202100774r · Cited by 23
Self-citationSong, C. J., Li, Z., Ahmed, U. K. B., Bland, S. J., Yashchenko, A., Liu, S., Aloria, E. J., Lever, J. M., Gonzalez, N. M., Bickel, M. A., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021030278 · Cited by 21
“Pkd1 mice have a knock-in missense mutation in the Pkd1 gene resulting in reduced levels of functional PC1 protein and slowly progressing cystic disease.(23,45) In the C57Bl/6 background, Pkd1 mice have slowly progressing disease (approximately 20% cystic index after 6 months) whereas in the BALB/c background the rate…”
BackgroundSelf-citationImmune checkpoint activity regulates polycystic kidney disease progression
Kleczko, E. K., Nguyen, D. T., Marsh, K. H., Bauer, C. D., Li, A. S., Monaghan, M. T., Berger, M. D., Furgeson, S. B., Gitomer, B. Y., Chonchol, M. B., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.161318 · Cited by 21
“As previously published, the model presents with varying disease course in different strains (10, 33, 34, 36, 37).”
InfluentialSelf-citationAutosomal dominant polycystic kidney disease: recent advances in clinical management
Mao, Z., Chong, J., & Ong, A. C. M. (2016) · F1000Research · doi:10.12688/f1000research.9045.1 · Cited by 21
Waldrop, E., Al-Obaide, M. A. I., & Vasylyeva, T. L. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00044 · Cited by 21
“With the range of clinical manifestations of ADPKD, the testing of patients with rapidly progressive ADPKD may show the presence of additional mutations in weak alleles that may affect the course and severity of their disease (Hopp et al., 2012).”
BackgroundIn vitro cyst formation of ADPKD cells
Sharma, M., Reif, G. A., & Wallace, D. P. (2019) · Methods in cell biology · doi:10.1016/bs.mcb.2019.05.008 · Cited by 21
Krappitz, M., Bhardwaj, R., Dong, K., Staudner, T., Yılmaz, D. E., Pioppini, C., Westergerling, P., Ruemmele, D., Hollmann, T., Nguyen, T. A., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021091180 · Cited by 21
Kidney disease: new technologies translate mechanisms to cure
O’Toole, J. F., & Sedor, J. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76825 · Cited by 21
“Animal models continue to have an important role in the study of cyst formation, where an emerging concept is the idea that a threshold level of polycystin activity exists, below which cystogenesis occurs (45, 46).”
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
BackgroundThe Biological Significance and Implications of Planar Cell Polarity for Nephrology
Papakrivopoulou, E., Jafree, D. J., Dean, C. H., & Long, D. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.599529 · Cited by 20
Li, Q., Wang, Y., Deng, W.-F., Liu, Y., Geng, J., Yan, Z., Li, F., Chen, B., Li, Z., Xia, R., et al. (2021) · Theranostics · doi:10.7150/thno.57220 · Cited by 20
“Previous studies used limited cellular markers and failed to identify cells negative for these markers [4, 13].”
ResultBeneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice
Hallows, K. R., Li, H., Saitta, B., Sepehr, S. H., Huang, P., Pham, J., Wang, J., Mancino, V., Chung, E. J., Pinkosky, S. L., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1001941 · Cited by 21
“, slower onset disease models, including the hypomorphic Pkd1 mouse model (Hopp et al., 2012), and in other inducible and Pkd2 mutant animal models).”
BackgroundAutosomal Dominant Polycystic Kidney Disease: A Path Forward
Rangan, G. K., Lopez‐Vargas, P. A., Nankivell, B. J., Tchan, M. C., Tong, A., Tunnicliffe, D. J., & Savige, J. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.10.002 · Cited by 20
“Along these lines, hypomorphic PKD allelic variants in combination with a completely inactive allele are also associated with more severe renal disease than carriage of the hypomorphic allele alone.(18,23) (4) Role of modifier genes and epigenetic factors: Twin and sibling studies have identified that modifier genes a…”
BackgroundDietary restriction regimens for fighting kidney disease: Insights from rodent studies
Singh, G., & Krishan, P. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110738 · Cited by 20
Wang, W., Silva, L. M., Wang, H. H., Kavanaugh, M. A., Pottorf, T. S., Allard, B. A., Jacobs, D. T., Dong, R., Cornelius, J. T., Chaturvedi, A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.04.034 · Cited by 21
Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD)
Peintner, L., & Borner, C. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2628-6 · Cited by 20
Prdx5 regulates DNA damage response through autophagy-dependent Sirt2-p53 axis
Agborbesong, E., Zhou, J. X., Li, L. X., Harris, P. C., Calvet, J. P., & Li, X. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac218 · Cited by 19
Self-citationVogel, P., Gelfman, C. M., Issa, T., Payne, B. J., Hansen, G. M., Read, R. W., Jones, C., Pitcher, M. R., Ding, Z., DaCosta, C. M., et al. (2014) · Veterinary Pathology · doi:10.1177/0300985814547392 · Cited by 19
“There is even evidence that the dosage level of the polycystins influences cyst development.(38) Despite the profound genetic and phenotypic differences between humans and mice, several mouse models have been invaluable in dissecting the genetic and molecular mechanisms involved in the pathogenesis of ciliopathies.”
BackgroundNon-Coding RNAs in Hereditary Kidney Disorders
Zhou, J. X., & Li, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063014 · Cited by 19
Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice
Chang, M., Tsai, C., Chou, L., Hsu, S., Yang, H., Hung, C., Tian, Y., Ong, A. C. M., & Yang, C. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab340 · Cited by 20
Generation of heterozygous PKD1 mutant pigs exhibiting early-onset renal cyst formation
Watanabe, M., Umeyama, K., Nakano, K., Matsunari, H., Fukuda, T., Matsumoto, K., Tajiri, S., Yamanaka, S., Hasegawa, K., Okamoto, K., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-021-00717-z · Cited by 19
The renal inflammatory network of nephronophthisis
Quatredeniers, M., Bienaimé, F., Ferri, G., Isnard, P., Porée, E., Billot, K., Birgy, É., Mazloum, M., Ceccarelli, S., Silbermann, F., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac014 · Cited by 19
The consequences of increased 4E-BP1 in polycystic kidney disease
Holditch, S. J., Brown, C. N., Atwood, D. J., Pokhrel, D., Brown, S., Lombardi, A. M., Nguyen, K. N., Hill, R. C., Lanaspa, M. A., Hopp, K., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz244 · Cited by 18
Self-citationLoss of polycystins suppresses deciliation via the activation of the centrosomal integrity pathway
Gerakopoulos, V., Ngo, P., & Tsiokas, L. (2020) · Life Science Alliance · doi:10.26508/lsa.202000750 · Cited by 18
Polycystin-2 (TRPP2) regulates primary cilium length in LLC-PK1 renal epithelial cells
Perez, P. L., Scarinci, N., Cantiello, H. F., & Cantero, M. D. R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.995473 · Cited by 18
“Renal tubular primary cilia also lengthen in several hypomorphic mouse mutants (Smith et al., 2006; Bergmann et al., 2008; Hopp et al., 2012), and abnormally”
BackgroundCaspase-1 and the inflammasome promote polycystic kidney disease progression
Swenson-Fields, K. I., Ward, C. J., Lopez, M. E., Fross, S., Dillon, A. L. H., Meisenheimer, J. D., Rabbani, A. J., Wedlock, E., Basu, M. K., Jansson, K. P., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.971219 · Cited by 18
“R3277C) or “RC,” that matches an allele found in a human family with cystic disease (Hopp et al., 2012).”
BackgroundSelf-citationIs it Time to Fold the Cysts Away?
Krappitz, M., Gallagher, A., & Fedeles, S. V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.10.001 · Cited by 17
“Leads passing secondary in vitro screening would then be confirmed in relevant orthologous early onset mouse models of ADPKD (harboring missense mutations in the REJ/GAIN domain of PC1) to demonstrate improved PC1 function and reduced ADPKD symptoms [9].”
BackgroundIFT‐A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease
Wang, W., Pottorf, T. S., Wang, H. H., Dong, R., Kavanaugh, M. A., Cornelius, J. T., Dennis, K. L., Apte, U. M., Pritchard, M. T., Sharma, M., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5685 · Cited by 17
Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement
Righini, M., Mancini, R., Busutti, M., & Buscaroli, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052554 · Cited by 17
Huang, Y., Osouli, A., Pham, J., Mancino, V., O’Grady, C., Khan, T., Chaudhuri, B., Pastor‐Soler, N. M., Hallows, K. R., & Chung, E. J. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01397 · Cited by 17
Non-canonical CDK6 activity promotes cilia disassembly by suppressing axoneme polyglutamylation
He, K., Sun, X., Chen, C., Luc, S., Hao, J., Zhang, Y., Huang, Y., Ji, B., Ku, P.-I., Subramanian, R., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202405170 · Cited by 17
MicroRNAs and Polycystic Kidney Disease
Li, D., & Sun, L. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2020.06.013 · Cited by 17
“Amousemodel mimicking the hypomorphic PKD1 allele showed the association of the functional PC1 dosage to disease severity.(37)”
BackgroundCongenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease
Chedid, M., Hanna, C., Zaatari, G., Mkhaimer, Y. G., Prajwal, R., Rangel, L. J., Zubidat, D., Kaidbay, D.-H. N., Irazabal, M. V., Connolly, H. M., et al. (2022) · American Journal of Nephrology · doi:10.1159/000522377 · Cited by 17
Self-citationAnalysis of primary cilia in renal tissue and cells
Silva, L. M., Wang, W., Allard, B. A., Pottorf, T. S., Jacobs, D. T., & Tran, P. V. (2019) · Methods in cell biology · doi:10.1016/bs.mcb.2019.04.008 · Cited by 17
Liu, Z., Liu, Y., Dang, L., Geng, M., Sun, Y., Lu, Y. H., Fang, Z., Xiong, H., & Chen, Y. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010101 · Cited by 18
“The collecting duct (CD) is the most affected renal tubular segment in ADPKD, especially in the late stage of the disease, when more than half of the renal cysts are of CD origin.(33) We isolated cells positive for DBA, a CD/tubule marker, from mouse kidneys.”
BackgroundKidney stone formation in a novel murine model of polycystic kidney disease
Riddle, H. A., Zhang, S., Qian, F., Williams, J. C., Stubbs, J. R., Rowe, P. S., & Parnell, S. C. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00165.2021 · Cited by 16
Metadata
- Authors
- Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Peter C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4257-4273
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484456
- OpenAlex
- W2085346322
- Cited by
- 442
- References
- 112
- Citations by year
- 2026: 34 · 2025: 34 · 2024: 45 · 2023: 43 · 2022: 44 · 2021: 44 · 2020: 38 · 2019: 23 · 2018: 19 · 2017: 20 · 2016: 21 · 2015: 31 · 2014: 26 · 2013: 18
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic (DK090728)
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-058816, DK090728, R01DK044863, P30DK090728, R01DK058816)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- autosomal dominant polycystic kidney disease, polycystin-1, PKD1, hypomorphic allele, dosage dependence, disease severity, cyst formation, knockin mouse model, primary cilia, collecting duct, temperature-sensitive mutants, phenotypic variability
- MeSH terms
- Animals, Disease Models, Animal, Severity of Illness Index, Polycystic Kidney, Autosomal Dominant, Protein Folding, Amino Acid Substitution, Mutation, Missense, Animals, Genetically Modified, TRPP Cation Channels, Mice, Gene Knock-In Techniques, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.